PBK and skin squamous cell carcinoma: Roh, Lee et al. have reported that the T-LAK cell-originated protein kinase (TOPK) and p53-related protein kinase (PRPK) are critical players in the development of skin malignancy and that targeting PRPK with rocuronium bromide (RocBr) could inhibit the development of cSCC [5].